Related Experiment Videos

The p53 tumor suppressor targets a novel regulator of G protein signaling

L Buckbinder1, S Velasco-Miguel, Y Chen

  • 1Department of Molecular Genetics, Oncology, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543, USA.

Insights

Researchers identified a new p53 target gene, A28-RGS14, activated by genotoxic stress. This gene regulates G protein signaling, potentially controlling cell sensitivity to growth factors via G protein-coupled receptors.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Cancer research

Background:

  • Heterotrimeric G proteins are key signal transducers for growth factors and intracellular signals.
  • These pathways can activate mitogen-activated or stress-activated protein kinases.

Purpose of the Study:

  • To identify novel p53 target genes involved in cellular stress response.
  • To investigate the role of A28-RGS14 in G protein signaling and cellular sensitivity to growth factors.

Main Methods:

  • Identification of a novel p53 target gene (A28-RGS14) induced by genotoxic stress.
  • Characterization of A28-RGS14 as a regulator of G protein signaling (RGS) protein.
  • Overexpression studies in mammalian cells to assess effects on mitogen-activated protein kinase (MAPK) signaling.

Main Results:

  • A28-RGS14 encodes a novel RGS protein with proposed GTPase-activating protein activity.
  • Overexpression of A28-RGS14p inhibits both Gi- and Gq-coupled receptor-mediated MAPK activation.
  • p53-induced A28-RGS14 may modulate cellular responses to growth and survival factors.

Conclusions:

  • A28-RGS14 is a novel p53 target gene induced by genotoxic stress.
  • A28-RGS14 negatively regulates G protein-coupled receptor signaling pathways.
  • p53-mediated induction of A28-RGS14 offers a mechanism to control cellular sensitivity to growth factors.

Related Concept Videos